Abstract:By means of introgressing a loss-of-function mutation in the p22phox gene from the Matsumoto Eosinophilia Shinshu (MES) rat to stroke-prone spontaneously hypertensive rats (SHRSP), we constructed the SHRSP-based congenic strain lacking the P22PHOX expression (i.e., lacking NADPH oxidases [NOX] activities) (SHRSP.MES-Cyba
mes/Izm; hereafter referred to as SP.MES). To examine the effects of Nox activities on the focal ischemic injury or stroke, we performed middle cerebral artery (MCA) occlusion in this new cong… Show more
“…S3b and ref. 7). Since P22PHOX is an essential subunit of the active NOX, the ROS level was expected to be low in SP.MES, and indeed, DHE staining (see below for the method) showed a lower level of superoxide in RVLM in SP.MES (Fig.…”
Section: Methodsmentioning
confidence: 99%
“…To examine this hypothesis, we introduced a P22PHOX-depleted congenic SHRSP, which was recently developed in our laboratory7. This congenic strain (called as SP.MES) was established to harbor the null mutation in the P22phox gene of the Matsumoto Eosinophilic Shinshu rat (MES)8.…”
Oxidative stress in the rostral ventrolateral medulla (RVLM), a sympathetic center in the brainstem, was implicated in the regulation of sympathetic activity in various hypertensive models including stroke-prone spontaneously hypertensive rats (SHRSP). In this study, we evaluated the role of the NADPH oxidases (NOX) in the blood pressure (BP) regulation in RVLM in SHRSP. The P22PHOX-depleted congenic SHRSP (called SP.MES) was constructed by introducing the mutated p22phox gene of Matsumoto Eosinophilic Shinshu rat. BP response to glutamate (Glu) microinjection into RVLM was compared among SHRSP, SP.MES, SHR and Wistar Kyoto (WKY); the response to Glu microinjection was significantly greater in SHRSP than in SP.MES, SHR and WKY. In addition, tempol, losartan and apocynin microinjection reduced the response to Glu significantly only in SHRSP. The level of oxidative stress, measured in the brainstem using lucigenin and dihydroethidium, was reduced in SP.MES than in SHRSP. BP response to cold stress measured by telemetry system was also blunted in SP.MES when compared with SHRSP. The results suggested that oxidative stress due to the NOX activation in RVLM potentiated BP response to Glu in SHRSP, which might contribute to the exaggerated response to stress in this strain.
“…S3b and ref. 7). Since P22PHOX is an essential subunit of the active NOX, the ROS level was expected to be low in SP.MES, and indeed, DHE staining (see below for the method) showed a lower level of superoxide in RVLM in SP.MES (Fig.…”
Section: Methodsmentioning
confidence: 99%
“…To examine this hypothesis, we introduced a P22PHOX-depleted congenic SHRSP, which was recently developed in our laboratory7. This congenic strain (called as SP.MES) was established to harbor the null mutation in the P22phox gene of the Matsumoto Eosinophilic Shinshu rat (MES)8.…”
Oxidative stress in the rostral ventrolateral medulla (RVLM), a sympathetic center in the brainstem, was implicated in the regulation of sympathetic activity in various hypertensive models including stroke-prone spontaneously hypertensive rats (SHRSP). In this study, we evaluated the role of the NADPH oxidases (NOX) in the blood pressure (BP) regulation in RVLM in SHRSP. The P22PHOX-depleted congenic SHRSP (called SP.MES) was constructed by introducing the mutated p22phox gene of Matsumoto Eosinophilic Shinshu rat. BP response to glutamate (Glu) microinjection into RVLM was compared among SHRSP, SP.MES, SHR and Wistar Kyoto (WKY); the response to Glu microinjection was significantly greater in SHRSP than in SP.MES, SHR and WKY. In addition, tempol, losartan and apocynin microinjection reduced the response to Glu significantly only in SHRSP. The level of oxidative stress, measured in the brainstem using lucigenin and dihydroethidium, was reduced in SP.MES than in SHRSP. BP response to cold stress measured by telemetry system was also blunted in SP.MES when compared with SHRSP. The results suggested that oxidative stress due to the NOX activation in RVLM potentiated BP response to Glu in SHRSP, which might contribute to the exaggerated response to stress in this strain.
“…Because Nox1-4 need to form heterodimers with the membrane-bound p22 phox subunit [ 1 ], SP.MES lacks Nox activities on the background of the SHRSP. Although we have reported the results of photothrombotic distal MCAO in this new congenic strain [ 73 ], the findings are summarized below.…”
Section: Experimental Models Of Strokementioning
confidence: 99%
“…Physiological variables such as blood pressure are critically important in experimental stroke; for example, congenic removal of a blood pressure quantitative trait locus (decreased blood pressure by 12% or −29 mmHg) attenuated infarct size produced by MCAO [ 70 ]. Our previous study mentioned above showed slightly but significantly decreased blood pressure in SP.MES (i.e., Nox dysfunction due to the absence of p22 phox protein) when compared with SHRSP/PM0, suggesting that decreased levels of resting or pre-stroke blood pressure in hypertensive rats would attenuate infarct size produced by MCAO [ 73 ]. Therefore, decreases in blood pressure due to the absence of p22 phox may explain at least in part the protective effects against focal ischemic injury observed in SP.MES.…”
Several experimental studies have indicated that nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (Nox) exert detrimental effects on ischemic brain tissue; Nox-knockout mice generally exhibit resistance to damage due to experimental stroke following middle cerebral artery occlusion (MCAO). Furthermore, our previous MCAO study indicated that infarct size and blood-brain barrier breakdown are enhanced in mice with pericyte-specific overexpression of Nox4, relative to levels observed in controls. However, it remains unclear whether Nox affects the stroke outcome directly by increasing oxidative stress at the site of ischemia, or indirectly by modifying physiological variables such as blood pressure or cerebral blood flow (CBF). Because of technical problems in the measurement of physiological variables and CBF, it is often difficult to address this issue in mouse models due to their small body size; in our previous study, we examined the effects of Nox activity on focal ischemic injury in a novel congenic rat strain: stroke-prone spontaneously hypertensive rats with loss-of-function in Nox. In this review, we summarize the current literature regarding the role of Nox in focal ischemic injury and discuss critical issues that should be considered when investigating Nox-related pathophysiology in animal models of stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.